No.
I think the timing in this regard will be driven by the FDA. I think one of the things that came out of the BP chat session which some HC members very kindly shared with us was that they couldn't cheat and compress the chronology.
So it's not a money issue per se.
If I had to guess how much a Ph III trial would cost it would be $25m so the money will have to come from somewhere. Given the expectation that the next Ph II Rett trial would report somewhere in Jul-Dec 2016 that's another reason for my thinking.
I enjoy a good speculate but we really have to wait until end of year before we can really discuss this.
on the money, page-4
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |